Interleukin-6 Receptor Antagonist [EPC] - N0000190480

  1. Home
  2. Pharmacologic Class Index
  3. Interleukin-6 Receptor Antagonist [EPC] - N0000190480

Pharmacologic Class Information

Pharmacologic Code N0000190480
Pharmacologic Name Interleukin-6 Receptor Antagonist
Pharmacologic Uses
  • interleukin-6 (IL-6) receptor antagonist
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Interleukin-6 Receptor Antagonist

The following table contains 9 products whose active ingredient are classified under the same pharmacologic class Interleukin-6 Receptor Antagonist [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0024-5908Kevzara Non-Proprietary Name: SarilumabInjection, SolutionSubcutaneousSanofi-aventis U.s. LlcACTIVE
0024-5910Kevzara Non-Proprietary Name: SarilumabInjection, SolutionSubcutaneousSanofi-aventis U.s. LlcACTIVE
0024-5920Kevzara Non-Proprietary Name: SarilumabInjection, SolutionSubcutaneousSanofi-aventis U.s. LlcACTIVE
0024-5922Kevzara Non-Proprietary Name: SarilumabInjection, SolutionSubcutaneousSanofi-aventis U.s. LlcACTIVE
50242-135Actemra Non-Proprietary Name: TocilizumabInjection, Solution, ConcentrateIntravenousGenentech, Inc.ACTIVE
50242-136Actemra Non-Proprietary Name: TocilizumabInjection, Solution, ConcentrateIntravenousGenentech, Inc.ACTIVE
50242-137Actemra Non-Proprietary Name: TocilizumabInjection, Solution, ConcentrateIntravenousGenentech, Inc.ACTIVE
50242-138Actemra Non-Proprietary Name: TocilizumabInjection, SolutionSubcutaneousGenentech, Inc.ACTIVE
50242-143Actemra Actpen Non-Proprietary Name: TocilizumabInjection, SolutionSubcutaneousGenentech, Inc.ACTIVE